glp-1 news 2025 november Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook Eli Lilly to seek approval
Description
Medication alone isnt enoughlasting results require the right nutrition, exercise, and lifestyle support
See NIH ODS for the data
The improvement in both HS-PGA and DLQI was possibly due to combined actions of weight loss and GLP-1 receptor activation
In this section, we review rodent model studies examining the impacts of ghrelin and GLP-1 on conditioned flavor avoidance (CFA) where a neutral flavor is paired to an ip injection of some compound that may produce nausea (e.g., lithium chloride), as well as on pica, the consumption of non-nutritive items such as kaolin as a means to relieve nausea
